Rethinking Clinical Trials Reform During the COVID-19 Pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rethinking Clinical Trials Reform During the COVID-19 Pandemic

Published:2020-09-01 Issue:9 Volume:6 Page:1327
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Nabhan Chadi¹²,Choueiri Toni K.³,Mato Anthony R.⁴

Affiliation:

1. Caris Life Sciences, Precision Oncology Alliance, Irving, Texas

2. Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia

3. Dana-Farber Cancer Institute, Boston, Massachusetts

4. Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2769129/jamaoncology_nabhan_2020_vp_200027_1599155269.50455.pdf

Reference8 articles.

1. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020

2. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation.;Unger;J Natl Cancer Inst,2019

3. Telehealth transformation: COVID-19 and the rise of virtual care.;Wosik;J Am Med Inform Assoc,2020

4. COVID-19 vaccines: breaking record times to first-in-human trials.;Kim;NPJ Vaccines,2020

5. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.;Basch;JAMA,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is Ailing Oncology Clinical Trials? Can We Fix Them?;Current Oncology;2024-06-28

2. TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic;Cancer Medicine;2024-03

3. Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center;Neoplasia;2023-12

4. Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic;JCO Oncology Practice;2023-11

5. Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology;Exploration of Targeted Anti-tumor Therapy;2023-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3